Vivos therapeutics announces receipt of notice from nasdaq regarding late filing of third quarter 2022 quarterly report on form 10-q

Vivos expects to become current on its sec filings in the coming weeks vivos expects to become current on its sec filings in the coming weeks

VVOS Ratings Summary

VVOS Quant Ranking